Harrow Inc (NASDAQ:HROW): An Affordable Growth Play Combining Rapid Expansion with Reasonable Valuation
Harrow Inc HROW
$33.00
โฒ +0.12%
(+$0.04)
Open
$33.39
Prev Close
$32.96
Day Range
$32.19 โ $33.39
52W Range
$25.21 โ $54.85
Market Cap
$1.23B
Beta
0.28
EPS (TTM)
$-0.16
๐ Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2013-02-08 |
| Shares Out. | 37,280,000 |
| Website | harrow.com/ โ |
| Phone | 16157334731 |
Harrow Inc is a publicly traded company under the ticker symbol HROW on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
๐ Analyst Ratings
14 analysts (2026-05-01)
๐ฐ Latest News for HROW
Harrow: Demand Keeps It Interesting, Valuation Keeps It A Hold
Harrow, Inc. 2026 Q1 - Results - Earnings Call Presentation
HROW Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Harrow for Potential Securities Law Violations
Cantor Fitzgerald Maintains Overweight on Harrow, Lowers Price Target to $88
Harrow, Inc. (HROW) Q1 2026 Earnings Call Transcript
Transcript : Harrow, Inc., Q1 2026 Earnings Call, May 12, 2026
12 Health Care Stocks Moving In Tuesday's Intraday Session
